Roche Deal for Flatiron Health Builds its Oncology Muscle

Roche Deal for Flatiron Health Builds its Oncology Muscle

Roche (SIX: RO) couldn’t let a good startup slip away. The Swiss drug maker announced it will pay $1.9 billion to keep New York City-based Flatiron Health, Inc. from going public. When it was founded in 2012, Flatiron’s goal was to gather and analyze data on cancer treatments and sells software based on those insights to help researchers develop drugs more quickly, and with more targeted precision. Toward that end, the company produced an oncology-specific electronic health record (EHR). It currently partners with more than 265 community cancer clinics, six major academic research centers and 14 out of the top 15 therapeutic oncology companies. Roche already holds a 12.6% stake... Read More »
Netsmart Adds HomeCare Accounting Solutions

Netsmart Adds HomeCare Accounting Solutions

Mergers and acquisitions in the Home Health & Hospice space are charging into 2018. Six deals were announced in the sector for the month of January, and more will likely turn up in the coming weeks. January’s total is already about half of the number of deals announced in this sector in the fourth quarter of 2017. It’s no surprise then that companies providing ancillary services to home health and hospice companies are seeing a surge in investor interest. Netsmart Technologies, jointly owned by Allscripts Healthcare Solutions (NYSE: MDRX) and GI Partners, has been building out front-office software solutions (think electronic health records) for providers in this area. Now... Read More »

2017 Biggest Healthcare Deals by Sector

2017 was another big year for billion-dollar healthcare transactions. Among the deals that disclosed prices, 44 topped the billion-dollar mark, for a total of approximately $263.1 billion. Although that number seems high, there were 50 billion-dollar deals announced in 2015, although those totaled a slightly lower $240.1 billion. 2016 posted lower totals for both the number of billion-dollar deals (39) and combined prices ($194.1 billion). Of course the biggest healthcare deal in 2017 was the $77 billion acquisition of Aetna Inc. (NYSE: AET) by CVS Health (NYSE: CVS). But there were many more sizable transactions across the sectors, as the chart below illustrates. See how many you remember... Read More »
Deal of the Week: Elsevier/Via Oncology

Deal of the Week: Elsevier/Via Oncology

Deal makers took a break last week, after a long trudge through the J.P. Morgan Healthcare Conference the week before. Deal volume was light in the week of Janaury 17, 2018, but at least 70 transactions have been recorded this month. Here’s an unusual deal from the eHealth sector we picked. Elsevier, a subsidiary of RELX plc (NYSE: RELX), announced its acquisition of Via Oncology, a privately held, former subsidiary of UPMC, based in Pittsburgh. Elsevier is a global provider of information solutions for science, health and technology professionals. Via Oncology provides decision support tools for cancer. Specifically, its Via Pathways product helps cancer centers demonstrate the... Read More »
Allscripts Adds Practice Fusion

Allscripts Adds Practice Fusion

Allscripts Healthcare Solutions (NASDAQ: MDRX) is back in buying mode. The healthcare technology company announced two deals back in August 2017, picking off McKesson’s (NYSE: MCK) hospital and health IT portfolio for $185 million, and then NantHealth’s (NASDAQ: NH) electronic health record (EHR) assets for an undisclosed price. This time, the target is Practice Fusion, a Silicon Valley startup focused on creating affordable certified cloud-based EHR systems for small, independent physician practices. As small as that market may seem, the company now supports 30,000 ambulatory practices and 5 million patient visits per month. The deal is a strategic one for Allscripts,... Read More »
Allscripts Adds Practice Fusion

eHealth Deals Dipped in Q3:2017

Merger and acquisition activity in the eHealth sector decreased in the third quarter, down 5% compared with the previous quarter, to 42 deals. However, the quarter’s results were 45% higher than the same period a year earlier. The third quarter’s total represents a 26% share of the 164 deals announced in the previous 12 months. Information technology underpins every aspect of the healthcare industry, as it does in virtually every other market. The repeal-and-replace effort has had little impact on investor interest in this sector, as technology stocks continue to dominate the equity markets. Source: HealthCareMandA.com, October 2017 Of the 42 deals announced in Q3:17, only seven disclosed... Read More »